GlassScriptPhysician profile
Kathleen Boyle
NPI 1255750675
$154,656.84
in general payments reported to CMS, 2019-2025
11 companies · $86K in 2025
The $86K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,926 · 2021: $2,176 · 2022: $1,291 · 2023: $3,117 · 2024: $60K · 2025: $86K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $118K · Travel and Lodging: $23K · Food and Beverage: $7,934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $118,200.00 |
| Travel and Lodging | $23,129.97 |
| Food and Beverage | $7,934.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $152,930.30 | 2020-2025 | Mako, Triathlon, Insignia |
| Smith+Nephew, INC. | $1,004.72 | 2020-2025 | Redapt, Journey II, Or3o Dual Mobility |
| Pixee Medical INC. | $189.94 | 2025 | |
| Zimmer Biomet Holdings, INC. | $134.64 | 2024 | Mymobility Platform |
| Heron Therapeutics, INC. | $125.67 | 2025 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $124.99 | 2022 | |
| Depuy Synthes Sales INC. | $42.62 | 2025 | |
| Next Science LLC | $37.75 | 2025 | Blastx, Xperience |
| Janssen Biotech, INC. | $34.01 | 2025 | Stelara, Tremfya, Simponi |
| Biocomposites INC | $22.72 | 2025 | Stimulan |
| Heraeus Medical, LLC. | $9.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Boyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.